Cargando…
Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model
BACKGROUND: Dopamine (DA) is a critical neuromodulator in the retina. Disruption of retinal DA synthesis and signaling significantly attenuates light-adapted, electroretinogram (ERG) responses, as well as contrast sensitivity and acuity. As these measures can be detected noninvasively, they may prov...
Autores principales: | Dai, Heng, Jackson, Chad R., Davis, Gwynne L., Blakely, Randy D., McMahon, Douglas G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745861/ https://www.ncbi.nlm.nih.gov/pubmed/29281965 http://dx.doi.org/10.1186/s11689-017-9215-8 |
Ejemplares similares
-
SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking
por: Bowton, E, et al.
Publicado: (2014) -
Serotonin transporter inhibition and 5-HT(2C) receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice
por: Stewart, Adele, et al.
Publicado: (2018) -
Male DAT Val559 Mice Exhibit Compulsive Behavior under Devalued Reward Conditions Accompanied by Cellular and Pharmacological Changes
por: Stewart, Adele, et al.
Publicado: (2022) -
Enhanced Dopamine Transmission and Hyperactivity in the Dopamine Transporter Heterozygous Mice Lacking the D3 Dopamine Receptor
por: Sotnikova, Tatyana D., et al.
Publicado: (2020) -
Association study of promoter polymorphisms at the dopamine transporter gene in Attention Deficit Hyperactivity Disorder
por: Xu, Xiaohui, et al.
Publicado: (2009)